Pancreatic Cancer Research

ResearcherFirst Affiliated Hospital of Xi'an Jiaotong UniversityNo recent work listed

Jiangbo Liu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-8781-0414; OpenAlex author ID A5035662043. Sources: OpenAlex.

Their work

Papers
8 (first author 2, last author 0)
Trials
0
Grants
0
Labs led
0
Collaborators
24
Papers, trials and grants by year

2013: 3 papers · 2014: 2 papers · 2015: none · 2016: 1 paper · 2017: 1 paper · 2018: none · 2019: 1 paper

Papers 8

  1. Analysis of the autophagy gene expression profile of pancreatic cancer based on autophagy-related protein microtubule-associated protein 1A/1B-light chain 3. Co-author DOI 10.3748/wjg.v25.i17.2086↗
  2. Relationship between autophagy and perineural invasion, clinicopathological features, and prognosis in pancreatic cancer. First author DOI 10.3748/wjg.v23.i40.7232↗
  3. Curcumin inhibits H2O2-induced invasion and migration of human pancreatic cancer via suppression of the ERK/NF-κB pathway. First author DOI 10.3892/or.2016.5044↗
  4. Arginine deiminase augments the chemosensitivity of argininosuccinate synthetase-deficient pancreatic cancer cells to gemcitabine via inhibition of NF-κB signa… Co-author DOI 10.1186/1471-2407-14-686↗
  5. Hyperglycemia regulates TXNIP/TRX/ROS axis via p38 MAPK and ERK pathways in pancreatic cancer. Co-author DOI 10.2174/1568009614666140331231658↗
  6. Neurotransmitter substance P mediates pancreatic cancer perineural invasion via NK-1R in cancer cells. Co-author DOI 10.1158/1541-7786.mcr-12-0609↗
  7. Indometacin ameliorates high glucose-induced proliferation and invasion via modulation of e-cadherin in pancreatic cancer cells. Co-author DOI 10.2174/09298673113209990249↗
  8. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway. Co-author DOI 10.2174/09298673113209990251↗

Closest collaborators

The 24 strongest of 24 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Yanhui Yang · 2 shared papers, 2017–2019 · strength 0.20
  2. Qingyong Ma · 5 shared papers, 2013–2014 · strength 0.18
  3. Erxi Wu · 5 shared papers, 2013–2014 · strength 0.18
  4. Wei Li · 3 shared papers, 2013–2016 · strength 0.14
  5. Wanxing Duan · 4 shared papers, 2013–2014 · strength 0.14
  6. Qinhong Xu · 4 shared papers, 2013–2014 · strength 0.14
  7. Yuxiang Zhang · 1 shared paper, 2019 · strength 0.11
  8. Hua Fan · 1 shared paper, 2019 · strength 0.11
  9. Liang Han · 3 shared papers, 2013–2014 · strength 0.11
  10. Jiguang Ma · 3 shared papers, 2013–2014 · strength 0.11
  11. Liangliang Lei · 1 shared paper, 2017 · strength 0.09
  12. Shuijun Zhang · 1 shared paper, 2017 · strength 0.09
  13. Katie M. Reindl · 2 shared papers, 2014 · strength 0.08
  14. Lei Cao · 1 shared paper, 2016 · strength 0.08
  15. Lun Zhang · 1 shared paper, 2016 · strength 0.08
  16. Zheng Wu · 1 shared paper, 2014 · strength 0.04
  17. Wei Li · 1 shared paper, 2014 · strength 0.04
  18. Wei Li · 1 shared paper, 2013 · strength 0.03
  19. Liang Han · 1 shared paper, 2013 · strength 0.03
  20. Han Liu · 1 shared paper, 2013 · strength 0.03
  21. Liang Han · 1 shared paper, 2013 · strength 0.03
  22. Qing Sun · 1 shared paper, 2013 · strength 0.03
  23. Xuqi Li · 1 shared paper, 2013 · strength 0.03
  24. Zheng Wang · 1 shared paper, 2013 · strength 0.03

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.